The Second Opinion Framework: When to Escalate From Telehealth to Derm

Telehealth-prescribed finasteride and minoxidil is appropriate care for most men with AGA. A specific set of presentations warrants in-person dermatological evaluation that telehealth cannot adequately provide.

Telehealth has dramatically expanded access to evidence-based AGA treatment by removing barriers of appointment scheduling, travel, and cost. This expansion is largely positive — more men with classic AGA receive finasteride and minoxidil earlier in their disease course. But telehealth has inherent diagnostic limitations that make in-person dermatological evaluation essential for certain presentations.

Presentations appropriate for telehealth management

The typical AGA presentation that telehealth handles well: patterned frontal recession and/or vertex thinning in a man with positive family history, gradual onset over years, no scalp symptoms (pain, pruritus, erythema, scaling), normal scalp skin visible on photographs, and otherwise good health. In this common scenario, the clinical probability of AGA is high, the response to finasteride with or without minoxidil is predictable, and monitoring progress via standardised photographs over 12 months is feasible.

Red flags warranting in-person evaluation

Rapidly progressive loss: AGA progresses over years. Hair loss progressing dramatically over weeks to months suggests a different process — alopecia areata, TE from systemic disease, or scarring alopecia — none of which are managed with the same AGA protocol.

Patchy distribution: Circular or geographic patches of complete hair absence are the classic presentation of areata and require direct examination, dermoscopy, and possibly biopsy to confirm and distinguish from other causes of patchy loss.

Scalp symptoms: Pain, burning, tenderness, or significant pruritus are not features of AGA. They suggest an inflammatory or infectious scalp condition requiring direct examination and potentially culture, biopsy, or both.

Visible scalp changes: Erythema, scaling, follicular hyperkeratosis (plugging), atrophy, or visible scarring at follicle sites are features of inflammatory or scarring alopecias that require direct dermoscopy and biopsy for diagnosis. Photographs provided to telehealth providers may not capture these subtle findings with adequate resolution.

Treatment failure: AGA that fails to respond to 12–18 months of consistent finasteride and minoxidil at appropriate doses warrants evaluation to confirm the diagnosis, assess T/V ratio on trichoscopy, and consider whether biopsy, alternative diagnoses, or escalation to dutasteride or PRP is appropriate.

The hair restoration specialist tier

Above general dermatology is the hair restoration specialist — a physician or surgeon with advanced training in trichoscopy, scalp biopsy interpretation, and hair transplantation. For men with significant AGA considering transplantation, or those with advanced loss where medical management has plateaued, specialist evaluation provides both refined diagnostic assessment and the full range of procedural options.